An Integrated Markov State Model and Path Metadynamics Approach To Characterize Drug Binding Processes

Area of Science:

• Computational biophysics and molecular modeling.
• Pharmacology and drug discovery.
• Biochemistry and protein-ligand interactions.

Background:

• Understanding drug-target binding mechanisms is crucial for rational drug design.
• Accurate prediction of binding pathways and energetics remains a significant challenge.
• The β2-adrenergic receptor is a key target for various pharmaceutical agents.

Purpose of the Study:

• To develop and validate an integrated computational methodology for elucidating drug-target binding.
• To reconstruct the binding pathway and estimate the binding free energy of alprenolol to the β2-adrenergic receptor.
• To identify key mechanistic and energetic features governing protein-ligand complex formation.

Main Methods:

• Combined Molecular Dynamics (MD) simulations with Markov State Models (MSM).
• Employed Path Collective Variables (PCVs) and metadynamics for enhanced sampling.
• Applied the integrated approach to the alprenolol-β2-adrenergic receptor system.

Main Results:

• Successfully reconstructed the binding process of alprenolol to the β2-adrenergic receptor.
• Estimated the binding free energy of the antagonist to its target.
• Identified the minimum free energy pathway critical for complex formation.

Conclusions:

• The integration of MSM and PCVs provides an efficient protocol for studying complex biological recognition.
• This methodology offers valuable mechanistic and energetic insights into drug-target interactions.
• The findings advance computational strategies in biophysics and drug discovery.